Company Overview
Snapshot
Founded in January 2023, Fe-Free operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing a novel non-invasive medical technology to address antibiotic-resistant infections by dispersing biofilm.
Business overview
Fe-Free is a Health Tech & Life Sciences company developing a unique, innovative non-invasive medical technology designed to disperse biofilm in antibiotic-resistant infections. The company's core technology aims to tackle chronic and recurrent microbial infections in humans, which are largely caused by biofilm. Fe-Free operates within the Pharma & Medical Biotechnology sector, targeting the healthcare and life sciences markets, specifically healthcare providers.
Log in to access full profile ›Company Intelligence Q&A
- What is Fe-Free's primary focus?
- Fe-Free is focused on developing a unique, innovative non-invasive medical technology to disperse biofilm in antibiotic-resistant infections, addressing a significant challenge in chronic and recurrent microbial infections.
- When was Fe-Free founded?
- Fe-Free was founded in January 2023.
- What stage of development is Fe-Free's product in?
- Fe-Free's product is currently in the R&D stage, with proof-of-concept demonstrated in a flow cell experiment on a Pseudomonas aeruginosa culture, showing a 71% reduction in live bacteria within the biofilm compared to a control culture.
- What is the employee count for Fe-Free?
- Fe-Free currently has 1–10 employees.
- What is the primary sector Fe-Free operates in?
- Fe-Free operates primarily in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology.